Literature DB >> 30392756

Autophagy-lysosomal defect in human CADASIL vascular smooth muscle cells.

Evelyn S Hanemaaijer1, Mahmod Panahi1, Nol Swaddiwudhipong1, Saara Tikka2, Bengt Winblad1, Matti Viitanen3, Antonio Piras4, Homira Behbahani5.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a familial progressive degenerative disorder and is caused by mutations in NOTCH3 gene. Previous study reported that mutant NOTCH3 is more prone to form aggregates than wild-type NOTCH3 and the mutant aggregates are resistant to degradation. We hypothesized that aggregation or accumulation of NOTCH3 could be due to impaired lysosomal-autophagy machinery in VSMC. Here, we investigated the possible cause of accumulation/aggregation of NOTCH3 in CADASIL using cerebral VSMCs derived from control and CADASIL patients carrying NOTCH3R133C mutation. Thioflavin-S-staining confirmed the increased accumulation of aggregated NOTCH3 in VSMCR133C compared to VSMCWT. Increased levels of the lysosomal marker, Lamp2, were detected in VSMCR133C, which also showed co-localization with NOTCH3 using double-immunohistochemistry. Increased level of LC3-II/LC3-I ratio was observed in VSMCR133C suggesting an accumulation of autophagosomes. This was coupled with the decreased co-localization of NOTCH3 with LC3, and Lamp2 and, further, increase of p62/SQSTM1 levels in VSMCR133C compared to the VSMCWT. In addition, Western blot analysis indicated phosphorylation of p-ERK, p-S6RP, and p-P70 S6K. Altogether, these results suggested a dysfunction in the autophagy-lysosomal pathway in VSMCR133C. The present study provides an interesting avenue of the research investigating the molecular mechanism of CADASIL.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Autophagy; CADASIL; LC3; Lysosomes; VSMC

Mesh:

Substances:

Year:  2018        PMID: 30392756     DOI: 10.1016/j.ejcb.2018.10.001

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  10 in total

Review 1.  CADASIL: new advances in basic science and clinical perspectives.

Authors:  Elisa A Ferrante; Cornelia D Cudrici; Manfred Boehm
Journal:  Curr Opin Hematol       Date:  2019-05       Impact factor: 3.284

Review 2.  Notch3 Signaling and Aggregation as Targets for the Treatment of CADASIL and Other NOTCH3-Associated Small-Vessel Diseases.

Authors:  Dorothee Schoemaker; Joseph F Arboleda-Velasquez
Journal:  Am J Pathol       Date:  2021-04-22       Impact factor: 4.307

Review 3.  CADASIL from Bench to Bedside: Disease Models and Novel Therapeutic Approaches.

Authors:  Arianna Manini; Leonardo Pantoni
Journal:  Mol Neurobiol       Date:  2021-01-19       Impact factor: 5.590

4.  ER stress and Rho kinase activation underlie the vasculopathy of CADASIL.

Authors:  Karla B Neves; Adam P Harvey; Fiona Moreton; Augusto C Montezano; Francisco J Rios; Rhéure Alves-Lopes; Aurelie Nguyen Dinh Cat; Paul Rocchicciolli; Christian Delles; Anne Joutel; Keith Muir; Rhian M Touyz
Journal:  JCI Insight       Date:  2019-12-05

5.  Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment.

Authors:  Elena Muiño; Olga Maisterra; Joan Jiménez-Balado; Natalia Cullell; Caty Carrera; Nuria P Torres-Aguila; Jara Cárcel-Márquez; Cristina Gallego-Fabrega; Miquel Lledós; Jonathan González-Sánchez; Ferran Olmos-Alpiste; Eva Espejo; Álvaro March; Ramón Pujol; Ana Rodríguez-Campello; Gemma Romeral; Jurek Krupinski; Joan Martí-Fàbregas; Joan Montaner; Jaume Roquer; Israel Fernández-Cadenas
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

6.  Decreased mitochondrial D-loop region methylation mediates an increase in mitochondrial DNA copy number in CADASIL.

Authors:  Jiewen Zhang; Junkui Shang; Fengyu Wang; Xuejing Huo; Ruihua Sun; Zhixia Ren; Wan Wang; Miaomiao Yang; Gai Li; Dandan Gao; Ruijie Liu; Pingping Bai; Shuyi Wang; Yanliang Wang; Xi Yan
Journal:  Clin Epigenetics       Date:  2022-01-04       Impact factor: 6.551

7.  Investigation of Mitochondrial Related Variants in a Cerebral Small Vessel Disease Cohort.

Authors:  P J Dunn; N R Harvey; N Maksemous; R A Smith; H G Sutherland; L M Haupt; L R Griffiths
Journal:  Mol Neurobiol       Date:  2022-06-14       Impact factor: 5.682

8.  Mechanisms regulating cerebral hypoperfusion in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  Xi Yan; Junkui Shang; Runrun Wang; Fengyu Wang; Jiewen Zhang
Journal:  J Biomed Res       Date:  2022-08-28

9.  SQSTM1 gene as a potential genetic modifier of CADASIL phenotype.

Authors:  Maria Rosário Almeida; Ana Rita Silva; Inês Elias; Carolina Fernandes; Rita Machado; Orlando Galego; Gustavo Cordeiro Santo
Journal:  J Neurol       Date:  2020-11-20       Impact factor: 4.849

Review 10.  Notch3 in Development, Health and Disease.

Authors:  Samira Hosseini-Alghaderi; Martin Baron
Journal:  Biomolecules       Date:  2020-03-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.